Previous 10 | Next 10 |
BIRKENHEAD, UK / ACCESSWIRE / February 24, 2022 / The Board of Directors (the "Board") of Alterola Biotech, Inc. (OTC PINK:ABTI) or (the "Company") is pleased to announce that the Company has filed an application to upgrade from the OTC PINK tier to the OTCQB tier of OTC Markets. Tim Rogers...
BIRKENHEAD, UK / ACCESSWIRE / January 3, 2022 / The Board of Directors (the "Board") of Alterola Biotech Inc. (OTC PINK:ABTI) or (the "Company") is pleased to announce that Mr. Guy Webber ("Mr. Webber") has been appointed as a Preclinical Development Director of the Company as of February 01...
BIRKENHEAD, UK / ACCESSWIRE / December 24, 2021 / Alterola Biotech Inc. (OTC PINK:ABTI) today announces the execution of a Memorandum of Understanding (MoU) to enter into a Good Manufacturing Practice (GMP) supply agreement with Averix Bio LLC ("AverixBio"), a North Carolina registered com...
BIRKENHEAD, UK / ACCESSWIRE / November 16, 2021 / Alterola Biotech Inc. ("Alterola Biotech" or the "Company") ( OTC PINK:ABTI ) today announced the agreement to purchase the assets from C2 Wellness Corporation. ("C2"), a Wyoming registered company with an address at 30 North Gould Street, ...
BIRKENHEAD, UK / ACCESSWIRE / November 12, 2021 / Alterola Biotech Inc. ("Alterola Biotech" or the "Company") (OTC PINK:ABTI) a clinical-stage biotechnology company focused on developing cannabinoid therapies for the treatment of diseases, having filed its Registration Statement on For...
BIRKENHEAD, UK / ACCESSWIRE / October 21, 2021 / Alterola Biotech Inc. (OTC PINK:ABTI) today announced that it has been made aware of further promotional activity concerning ALTEROLA common stock. On October 12 and October 13, 2021, several articles were published in a newsletter owned, op...
BIRKENHEAD, UK / ACCESSWIRE / October 15, 2021 / Alterola Biotech, Inc. (OTC PINK:ABTI) today announced that it has been made aware of certain promotional activity concerning ALTEROLA common stock. On October 12, 2021, the Company first became aware of certain promotional activities co...
LIVERPOOL, UK / ACCESSWIRE / September 23, 2021 / The Board of Directors (the "Board") of Alterola Biotech Inc , (OTC PINK:ABTI, ) or (the "Company") is pleased to announce that Mr. Hunter Land ("Mr. Land") has been appointed as a Director of the Company as of September 22, 2021. Mr. Land, a...
Alterola Biotech ([[ABTI]]) announces the acquisition of ABTI Pharma in a bid to move into the cannabinoid medicines sector.ABTI Pharma is a company developing novel cannabinoid, cannabinoid-like, and non-cannabinoid pharmaceutical medicines, active pharmaceutical ingredients ((APIs)) and oth...
Alterola Biotech, Inc. acquires ABTI Pharma Ltd. as part of its strategic move into the cannabinoid medicines sector. LIVERPOOL, UK / ACCESSWIRE / July 13, 2021 / Alterola Biotech, Inc. (OTC PINK:ABTI) , today announces the acquisition of ABTI Pharma Ltd., a company developing novel ca...
News, Short Squeeze, Breakout and More Instantly...
Alterola Biotech Inc Company Name:
ABTI Stock Symbol:
OTCMKTS Market:
Continued investment to support long-term strategy and pathway for growth, including plans to fully acquire Alterola Biotech, appointment of Seamus McAuley as Chief Executive Officer and expansion of Scientific Advisory Board Recently announced capital raise plan of $500+ million utiliz...
Terry Rafih to remain as Executive Chairman of the Board Appointment reinforces Company’s strategy to build out its team to deliver on the development of cannabis-based medicines and products, as well as its greenhouse expansion plans The Company confirms the receipt of i...
GRANTS, N.M., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and c...